Evidence map›Paper›PMID 24936366›Full record

ReviewBioscience of microbiota, food and health2013

Gut microbiota, probiotics, and human health.

Alexander Suvorov

Open access · hybridAbstract readReview
In one paragraph

Review in Bioscience of microbiota, food and health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Effects ofNutrients · 2022
    Trial
  3. Review
  4. Zoological research · 2024
    Article
  5. Article
  6. Prebiotic effect of galacto-Applied and environmental microbiology · 2024
    Article
  7. Probiotics and autoprobiotics for treatment ofWorld journal of clinical cases · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. What Is Wrong with Enterococcal Probiotics?Probiotics and antimicrobial proteins · 2020
    Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alexander Suvorov1 Department of Molecular Microbiology, Institute for Experimental Medicine, Acad. Pavlov Street 12, Saint-Petersburg 197376, Russia.
Institute of Experimental Medicine · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The review is devoted to the problems of microbiota and the ways of it correction employing beneficial life bacteria- probiotics. It covers the issues related to the functioning of human microbiota and its importance for the health, individual variability of microbial content, functioning of the probiotics in the human organism and the history of probiotic studies with particular focus on the microbiological investigations in the USSR. The article discusses the safety issues related to probiotics and the problems with probiotic therapy, trying to explain the reasons for the side effects caused by probiotics. The necessity of personified selection of the probiotic strain or individual microbial therapy autoprobiotics is also discussed.

Indexed as

enterotypemicrobiotaprobiotic

Identifiers

PMID24936366
PMCPMC4034364
OpenAlexW1999408855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.